Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.300
+0.070 (5.69%)
At close: Oct 8, 2025, 4:00 PM EDT
1.310
+0.010 (0.77%)
Pre-market: Oct 9, 2025, 8:12 AM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $29.10 million as of October 9, 2025. Its market cap has decreased by -70.28% in one year.
Market Cap
29.10M
Enterprise Value
-48.54M
1-Year Change
-70.28%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $29.10M, a decrease of -91.82%. That is a compound annual growth rate of -80.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 27.53M | -57.42% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.41B |
| Johnson & Johnson | 451.97B |
| AbbVie | 411.98B |
| UnitedHealth Group | 330.07B |
| AstraZeneca | 265.89B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.01B |